跳至主要内容
临床试验/NCT01706887
NCT01706887终止不适用

Clinical, Pharmacological and Biological Investigations of a Polymorphism of Nedd4 , a Regulatory Protein of the Epithelial Sodium Channel

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 219 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
219
主要终点
Difference in Blood Pressure among genotypes

研究概览

简要总结

Nedd4.2 is a regulator of ENac, a transporter of sodium involved in the regulation of salt retention by the kidney. The study address the consequence of a frequent genetic variation leading expected to impact the function of Nedd4 and in turn, the ability of kidneys to excrete salt intake. Our hypothesis is that the genetic variants of Nedd4.2 could constitute a genetic predisposition to (or protection against) salt-sensitive hypertension.

详细描述

Subjects were submitted one week to a low sodium-high potassium diet, and then switch to a high sodium,-low potassium diet for two weeks. the last week, subject were taken a 20 MG daily dose of amiloride, a potassium sparing diuretic.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • healthy volunteers
  • between 18 and 35 years odl
  • BMI between 18 and 28 Kg per m2
  • non smokers
  • no active disease
  • no alcool or drug abuse

排除标准

  • 未提供

结局指标

主要结局

Difference in Blood Pressure among genotypes

时间窗: 24h AMBP will be measured weekly for the duration of study, an expected average of 3 weeks

24h AMBP will be measured weekly for the duration of study, an expected average of 3 weeks

次要结局

  • Ambulatory Blood Pressure (AMBP)(three weeks)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Genetic Determinant of Blood Pressure Sensitivity to... | 临床试验